Data Published in Frontiers in Molecular Neuroscience Demonstrate That ZyVersa's Inflammasome ASC Inhibitor, IC 100, Is Effective in Reducing Brain Inflammation in a Preclinical Model of Aging
News Channel 11 wjhl.com,
Age-related chronic inflammation induced by activation of NLRP1 inflammasomes is implicated in development and progression of…